Skip to content
Back to Investors
Development Bank of Wales

Development Bank of Wales

Government

The Development Bank of Wales provides equity and loan financing to support business growth and technological innovation across Wales.


Recent investments

Seed
£500K

The online building supplies marketplace has raised capital to relocate to Cardiff and fund technological development.

"We are on a mission to consolidate the highly fragmented trade professional supplies market. The sector often relies on personal relationships to procure equipment but we are now offering a primary market aggregator that is proving very popular. Our aim is to not only offer a one-stop shop for trade professionals, but to also support local independent merchants by offering an online selling solution that is needed now more than ever."
— Phoebe Bull, Chief Operating Officer
Seed
£1.4M

The seed round was supported by a syndicate of investors including the Development Bank of Wales and the UKI2S Innovate Accelerator to fund platform development and laboratory expansion.

"Our investors recognise the potential of our AI-powered antibody drug discovery platform to provide a breakthrough in the industry. With our technology, it will be possible to develop drugs for difficult targets and ultimately reduce drug discovery timescales from years to weeks. In addition to platform development, the funding will enable us to invest in facilities and recruitment; we are grateful to our investors and Innovate UK for their continued support."
— Murat Tunaboylu, Co-Founder and CEO
Seed
£500K

The seed round was led by the Development Bank of Wales with backing from angel investors and Innovate UK.

"We’re delighted to have secured our first equity investment and very much look forward to continuing to grow and develop alongside the Development Bank of Wales and our Angel co-investors."
— Billy Williams, CEO
£1.5M

The funding round will support the rapid development of single use flexible endoscopes and facilitate the company relocation to Wales.

"IQ Endoscopes disruptive technology eliminates the risk of cross contamination which is at the forefront of clinicians’ minds at the moment with the prevalence of COVID-19. Practitioners can’t risk contamination between endoscopy procedures. Creating a disposable endoscope, which is expected to be positioned at a lower cost point than current technology, is an extremely thrilling prospect and the reason why Creo Medical is keen to support the product development to get IQ Scope and platform to market as quickly as possible."
— Craig Gulliford, Chief Executive Officer